Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 2456-2468, March 15, 2007. doi: 10.1158/0008-5472.CAN-06-2698
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaur, A.
Right arrow Articles by Israel, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaur, A.
Right arrow Articles by Israel, M. A.

Molecular Biology, Pathobiology, and Genetics

Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines

Arti Gaur1, David A. Jewell2, Yu Liang3, Dana Ridzon3, Jason H. Moore1,2, Caifu Chen3, Victor R. Ambros2 and Mark A. Israel1,2

1 Norris Cotton Cancer Center and 2 Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire; and 3 Molecular Cell Biology-R&D, Applied Biosystems, Foster City, California

Requests for reprints: Mark A. Israel, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03755. Phone: 603-653-3611; Fax: 603-653-9003; E-mail: Mark.A.Israel{at}dartmouth.edu.

MicroRNAs are small noncoding RNAs that function by regulating target gene expression posttranscriptionally. They play a critical role in developmental and physiologic processes and are implicated in the pathogenesis of several human diseases including cancer. We examined the expression profiles of 241 human microRNAs in normal tissues and the NCI-60 panel of human tumor-derived cell lines. To quantify microRNA expression, we employed a highly sensitive technique that uses stem-loop primers for reverse transcription followed by real-time PCR. Most microRNAs were expressed at lower levels in tumor-derived cell lines compared with the corresponding normal tissue. Agglomerative hierarchical clustering analysis of microRNA expression revealed four groups among the NCI-60 cell lines consisting of hematologic, colon, central nervous system, and melanoma tumor–derived cell lines clustered in a manner that reflected their tissue of origin. We identified specific subsets of microRNAs that provide candidate molecular signatures characteristic of the tumor-derived cell lines belonging to these four clusters. We also identified specific microRNA expression patterns that correlated with the proliferation indices of the NCI-60 cell lines, and we developed evidence for the identification of specific microRNAs as candidate oncogenes and tumor suppressor genes in different tumor types. Our results provide evidence that microRNA expression patterns may mark specific biological characteristics of tumors and/or mediate biological activities important for the pathobiology of malignant tumors. These findings call attention to the potential of microRNAs to provide etiologic insights as well as to serve as both diagnostic markers and therapeutic targets for many different tumor types. [Cancer Res 2007;67(6):2456–68]




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E. A. Chiocca, S. Lawler, et al.
microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma
Cancer Res., May 15, 2008; 68(10): 3566 - 3572.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. A. Cole, E. F. Attiyeh, Y. P. Mosse, M. J. Laquaglia, S. J. Diskin, G. M. Brodeur, and J. M. Maris
A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene
Mol. Cancer Res., May 1, 2008; 6(5): 735 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. N. Nikiforova, G. C. Tseng, D. Steward, D. Diorio, and Y. E. Nikiforov
MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1600 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-i. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
Cancer Res., April 1, 2008; 68(7): 2094 - 2105.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Genes & Dev., April 1, 2008; 22(7): 894 - 907.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W.-X. Wang, B. W. Rajeev, A. J. Stromberg, N. Ren, G. Tang, Q. Huang, I. Rigoutsos, and P. T. Nelson
The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of {beta}-Site Amyloid Precursor Protein-Cleaving Enzyme 1
J. Neurosci., January 30, 2008; 28(5): 1213 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yang, W. Kong, L. He, J.-J. Zhao, J. D. O'Donnell, J. Wang, R. M. Wenham, D. Coppola, P. A. Kruk, S. V. Nicosia, et al.
MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
Cancer Res., January 15, 2008; 68(2): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
I. D. Moffat, P. C. Boutros, T. Celius, J. Linden, R. Pohjanvirta, and A. B. Okey
microRNAs in Adult Rodent Liver Are Refractory to Dioxin Treatment
Toxicol. Sci., October 1, 2007; 99(2): 470 - 487.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Shell, S.-M. Park, A. R. Radjabi, R. Schickel, E. O. Kistner, D. A. Jewell, C. Feig, E. Lengyel, and M. E. Peter
Let-7 expression defines two differentiation stages of cancer
PNAS, July 3, 2007; 104(27): 11400 - 11405.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. E. Blower, J. S. Verducci, S. Lin, J. Zhou, J.-H. Chung, Z. Dai, C.-G. Liu, W. Reinhold, P. L. Lorenzi, E. P. Kaldjian, et al.
MicroRNA expression profiles for the NCI-60 cancer cell panel
Mol. Cancer Ther., May 1, 2007; 6(5): 1483 - 1491.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.